3.01 (-%)
As of Nov 21, 2024
Source:
Gt Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products basedon our proprietary Tri-specific Killer Engager (TriKE ) fusion protein immune cell engager technology platform.
| Country | United States |
| Headquarters | brisbane, california |
| Phone Number | (800) 304-9888 |
| Industry | manufacturing |
| CEO | Michael Breen |
| Website | www.gtbiopharma.com |